Science & Enterprise subscription

Follow us on Twitter

  • Discoveries in a university lab that enable detection of Covid-19 infections from a person's breath are being licen… https://t.co/DgmvR2EcTr
    about 8 hours ago
  • New post on Science and Enterprise: Breath Analysis Sensor Licensed to Detect Covid-19 https://t.co/IZh1x1rqfo #Science #Business
    about 8 hours ago
  • Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinic… https://t.co/VvvPn7PGgu
    about 16 hours ago
  • New post on Science and Enterprise: Covid-19 Vaccines, Therapies – 10 August 2020 https://t.co/RY6ggjx9Eu #Science #Business
    about 16 hours ago
  • Physical symptoms experienced by people with Covid-19 infections are well documented, but the psychological toll is… https://t.co/e2pEpA3nlP
    about 3 days ago

Please share Science & Enterprise

Light-Enabled Nanoparticles Detect Early Infection Signs

Tuan Vo-Dinh (Duke University)

Tuan Vo-Dinh (Duke University)

Biomedical and genomic researchers at Duke University in North Carolina developed a technique with light and silver nanoparticles to detect infections earlier than when patients may even report symptoms. The team led by biomedical engineering professor Tuan Vo-Dinh and genomic medicine professor Geoffrey Ginsburg published its findings online in a recent issue of the journal Analytica Chimica Acta (paid subscription required).

The process devised by the Duke team adapts a method of visual energy measurement called surface-enhanced Raman scattering or SERS that detects the light scattered back from the interaction of a light beam with a physical sample. The scattered response, however, is usually weak, requiring an additional enhancement process, which makes it possible to detect scatters from samples as small as a single molecule.

In a proof-of-concept study Vo-Dinh, Ginsburg, and colleagues devised a nanoscale probe they call a molecular sentinel that uses silver nanoparticles with genetic material used in molecular assays. The silver nanoparticles bind to specific molecular biomarkers, in this case, a ribonucleic acid or RNA target for the RSAD2 gene, a biomarker for respiratory infections. Reflections from the target return a unique SERS pattern, providing an optical fingerprint for the biomarker.

Vo-Dinh says the binding of the silver with the biomarker vastly enhances the SERS technique, often by more than a million times. He adds that the tests reported in the paper were the first time these nanoprobes detected specific genetic materials in human samples.

The tests can be designed, say the researchers, to find the infection biomarkers as soon as they enter the blood stream, which may be sooner than the patient even reports symptoms of the infection. While the Duke study tested samples in the lab, the researchers used a portable Raman spectrometer for the tests, which indicates the technology can likely be engineered into point-of-care diagnostics for detecting early signs of infection.

Vo-Dinh, Ginsburg, and colleagues are developing the technique further so it can be placed on a chip device. The researchers say the diagnostic devices could also be designed to test for multiple biomarkers.

Read more:

*     *     *

Comments are closed.